Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks

International Journal of Gynecology and Obstetrics

Volumn 99, Issue SUPPL. 2, 2007, Pages

  Ho, P C ^a   Blumenthal, P D ^b   Gemzell Danielsson, K ^c   Gomez Ponce de Leon R ^d   Mittal, S ^e   Tang, O S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b STANFORD UNIVERSITY   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d IL   (United States)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Misoprostol; Second trimester; Termination of pregnancy

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIPYRETIC AGENT; GEMEPROST; MIFEPRISTONE; MISOPROSTOL; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN; PROSTAGLANDIN DERIVATIVE; RHESUS D ANTIBODY;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANTIBIOTIC THERAPY; CHILL; CLINICAL TRIAL; DIARRHEA; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FEVER; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INFECTION; INTRAUTERINE INFECTION; LOW DRUG DOSE; NAUSEA; NAUSEA AND VOMITING; PREGNANCY TERMINATION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RHESUS INCOMPATIBILITY; SEPSIS; UNSPECIFIED SIDE EFFECT; UTERUS RUPTURE; VAGINA BLEEDING; VOMITING;

EID: 36048977591     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.09.007     Document Type: Review

References (28)

1. Tietze C. Second-trimester abortion: a global view. In: Berger G.S., Brenner W.E., and Keith L.G. (Eds). Second-trimester Abortion (1981), John Wright, Boston 1-11
2. World Health Organization. Technical and Policy Guidance for Health Systems (2003), World Health Organization, Geneva
3. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion (2004), Royal College of Obstetricians and Gynaecologists, London
4. Ngai S.W., Tang O.S., and Ho P.C. Prostaglandins for induction of second-trimester termination and intrauterine death. Best Pract Res, Clin Obstet Gynaecol 17 (2003) 765-775
5. Paz B., Ohel G., Tal T., Degani S., Sabo E., and Levitan Z. Second trimester abortion by laminaria followed by vaginal misoprostol or intrauterine prostaglandin F2α: a randomized trial. Contraception 65 (2002) 411-413
6. Su L.L., Biswas A., Choolani M., Kalaichelvan V., and Singh K. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostagladins for midtrimester termination of pregnancy. Am J Obstet Gynecol 193 (2005) 1410-1414
7. 2 for second-trimester labor induction. Obstet Gynecol 104 (2004) 138-145
8. Dodd J.M., and Crowther C.A. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. Eur J Obstet Gynecol Reprod Biol 125 (2006) 3-8
9. Wong K.S., Ngai C.S.W., Wong A.Y.K., Tang L.C.H., and Ho P.C. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy: a randomized trial. Contraception 58 (1998) 207-210
10. Daskalakis G.J., Mesogitis S.A., Papantoniou N.E., Moulopoulos G.G., Papapanagiotou A.A., and Antsaklis A.J. Misoprostol for second trimester pregnancy termination in women with prior caesarean section. BJOG: an International Journal of Obstetrics and Gynaecology 112 (2005) 97-99
11. Tarim E., Kilicdag E., Bagis T., Ilgin A., and Yanik F. Second-trimester pregnancy termination with oral misoprostol in women who have had one cesarean section. Int J Gynecol Obstet 90 (2005) 84-85
12. Dickinson J.E. Misoprostol for second-trimester pregnancy termination in women with a prior caesarean delivery. Obstet Gynecol 105 (2005) 352-356
13. Nayki U., Taner C.E., Mizrak T., Nayki C., and Derin G. Uterine rupture during second trimester abortion with misoprostol. Fetal Diagn Ther 20 (2005) 469-471
14. Daskalakis G., Papantoniou N., Mesogitis S., Papageorgiou J., and Antsaklis A. Sonographic findings and surgical management of a uterine rupture associated with the use of misoprostol during second-trimester abortion. J Ultrasound Med 24 (2005) 1565-1568
15. Mazouni C., Provensal M., Porcu G., Guidicelli B., Heckenroth H., Gamerre M., et al. Termination of pregnancy in patients with previous cesarean section. Contraception 73 (2006) 244-248
16. Wong K.S., Ngai C.S.W., Yeo E.L.K., Tang L.C.H., and Ho P.C. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 15 (2000) 709-712
17. Rodger M.W., and Baird D.T. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 97 (1990) 41-45
18. Ho P.C., and Ma H.K. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial. Contraception 47 (1993) 123-129
19. El-Refaey H., and Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 10 (1995) 475-478
20. Webster D., Penney G.C., and Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 103 (1996) 706-709
21. Ho P.C., Ngai S.W., Liu K.L., Wong G.C.Y., and Lee S.W.H. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 90 (1997) 735-738
22. Nigam A., Singh V.K., and Prakash A. Vaginal vs. oral misoprostol for mid-trimester abortion. Int J Gynecol Obstet 92 (2006) 270-271
23. Tang O.S., Lau W.N.T., Chan C.C.W., and Ho P.C. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG: Int J Obstet Gynaecol 111 (2004) 1001-1005
24. Dickinson J.E., and Evans S.F. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 186 (2002) 470-474
25. Pongsatha S., and Tongsong T. Intravaginal misoprostol for pregnancy termination. Int J Gynecol Obstet 87 (2004) 176-177
26. Ashok P.W., Templeton A., Wagaarachchi P.T., and Flett G.M.M. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 69 (2004) 51-58
27. Fiala C., Swahn M.L., Stephansson O., and Gemzell-Danielsson K. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks of gestation. Hum Reprod 20 (2005) 3072-3077
28. Hamoda H., Ashok P.W., Flett G.M., and Templeton A. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. BJOG 111 (2004) 996-1000